Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. [PDF]
Pediatric Discovery, Volume 4, Issue 3, September 2026.
Bhatt AH +3 more
europepmc +5 more sources
Management and Treatment Outcomes of Hemolytic Disease of the Fetus and Newborn (HDFN)-A Retrospective Cohort Study. [PDF]
Background: Hemolytic disease of the fetus and newborn (HDFN) is caused by maternal antibodies attacking fetal blood cell antigens. Despite routine antenatal anti-D prophylaxis, intrauterine transfusions (IUTs) are still needed in some HDFN cases. Methods: We conducted a retrospective cohort study on newborns with HDFN born in the 1st Department of ...
Drozdowska-Szymczak A +4 more
europepmc +5 more sources
Maternal health, neonatology and perinatology towards a standardized outcome set for clinical trials in Hemolytic Disease of the Fetus and Newborn (HDFN): preliminary findings from two European advisory boards [PDF]
Hemolytic Disease of the Fetus and Newborn (HDFN) remains a serious perinatal condition worldwide despite major advances in antenatal and postnatal care.
Enrico Lopriore +6 more
doaj +3 more sources
Biphasic Behavior of Anti-M Antibody and Hemolytic Disease of the Fetus and Newborn (HDFN). [PDF]
The anti-M antibody is a cold, naturally occurring immunoglobulin M (IgM) antibody that is generally considered clinically insignificant and often overlooked in transfusion practices and assessments of patients at risk for hemolytic disease of the fetus and newborn (HDFN).
Barouqa M, Kilic H, Dela Cruz N.
europepmc +3 more sources
Understanding Patient Perspectives and Experiences in Severe Hemolytic Disease of the Fetus and Newborn: Insights from Qualitative Interviews [PDF]
Objective Maternal red cell alloimmunization is a rare pregnancy condition that can cause hemolytic disease of the fetus and newborn (HDFN), which can be serious and fatal. As subsequent alloimmunized pregnancies carry HDFN risk, families’
Adele Barlassina +6 more
doaj +2 more sources
Successful management of severe hemolytic disease of the fetus and newborn (HDFN) due to anti-Kell
Hemolytic disease of the fetus and newborn (HDFN) is a potentially life-threatening condition, caused by maternal alloimmune antibodies targeting fetal red blood cells.
Hrastar Erika +5 more
doaj +3 more sources
Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China [PDF]
. Objective:. To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes. Methods:
Quanrui Liu +7 more
doaj +2 more sources
Hemolytic Disease of the Fetus and Newborn due to an Anti-LU1 (anti-Lu<sup>a</sup>) Alloantibody: A Case Report [PDF]
Introduction: Many erythrocyte antibodies have been reported to cause hemolytic disease of the fetus and newborn (HDFN), but Lutheran (LU) alloantibodies are normally not involved in HDFN.
Elke Weinig +4 more
doaj +2 more sources
Understanding the consequences of being RhD immunized during pregnancy 10 years after introduction of targeted routine antenatal anti‐D prophylaxis: A retrospective nationwide cohort study [PDF]
Introduction Targeted routine antenatal anti‐D prophylaxis (RAADP) was introduced in Finland in 2014. The aim of this study was to assess the prevalence of anti‐D immunizations among pregnant women and the severity of hemolytic disease of the fetus and ...
Anna Parhamaa +8 more
doaj +2 more sources
Severe Hemolytic Disease of the Fetus Treated with Serial Intrauterine Transfusions: A Case Report and Review of Current Management [PDF]
Hemolytic disease of the fetus and newborn (HDFN) is a severe complication of pregnancy caused by maternal alloimmunization to fetal red blood cells, leading to significant perinatal morbidity and mortality.
Olga Olejniczak +2 more
doaj +2 more sources

